Personal information

Other IDs

SciProfiles: 2688462

Keywords

En bloc TUR, Cryoablation, CRPC, Laparoscopic radical cystectomy

Countries

Japan

Activities

Collapse all

Education and qualifications (1)

Jikei University School of Medicine: Tokyo, JP

2010-04 to present (Urology)
Education
Source: Self-asserted source
Takafumi Yanagisawa

Works (50 of 62)

Items per page:
Page 1 of 2

Tumor burden and heterogenous treatment effect of apalutamide in metastatic castration‐sensitive prostate cancer

Cancer
2025-04 | Journal article
DOI: 10.1002/cncr.35819
Contributors: Wataru Fukuokaya; Keiichiro Mori; Takafumi Yanagisawa; Fumihiko Urabe; Pawel Rajwa; Alberto Briganti; Shahrokh F. Shariat; Nobuaki Matsubara; Takahiro Kimura; Akihiro Hirakawa
Source: check_circle
Crossref

Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched Cohort

The Prostate
2025-04-08 | Journal article
DOI: 10.1002/pros.24898
Contributors: Tatsuya Shimomura; Fumihiko Urabe; Katsuki Muramoto; Takafumi Yanagisawa; Wataru Fukuokaya; Keiichiro Mori; Kojiro Tashiro; Kota Katsumi; Hidetsugu Takahashi; Kentaro Yoshihara et al.
Source: check_circle
Crossref

PSA Absolute Value Versus PSA Response Rate: Which Is More Valuable for Estimating Survival Outcomes With ARPI Treatment for Metastatic Hormone‐Sensitive Prostate Cancer (mHSPC) in Real‐World Analyses?

The Prostate
2025-04-06 | Journal article
DOI: 10.1002/pros.24885
Contributors: Tatsuya Shimomura; Naoki Otsuka; Fumihiko Urabe; Katsuki Muramoto; Takafumi Yanagisawa; Wataru Fukuokaya; Keiichiro Mori; Kojiro Tashiro; Kota Katsumi; Hidetsugu Takahashi et al.
Source: check_circle
Crossref

Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter study

The Prostate
2025-02 | Journal article
DOI: 10.1002/pros.24813
Contributors: Takafumi Yanagisawa; Wataru Fukuokaya; Shingo Hatakeyama; Shintaro Narita; Katsuki Muramoto; Kouta Katsumi; Hidetsugu Takahashi; Fumihiko Urabe; Keiichiro Mori; Kojiro Tashiro et al.
Source: check_circle
Crossref

Prognostic model for second progression‐free survival and overall survival in patients with high‐risk metastatic hormone‐sensitive prostate cancer treated with abiraterone acetate and androgen deprivation therapy

The Prostate
2025-01 | Journal article
DOI: 10.1002/pros.24802
Contributors: Shintaro Narita; Takafumi Yanagisawa; Shingo Hatakeyama; Kenichi Hata; Kazutoshi Fujita; Takashi Ueda; Toshikazu Tanaka; Shinya Maita; Shuji Chiba; Hiromi Sato et al.
Source: check_circle
Crossref

The potential benefits of concomitant statins treatment in patients with non‐muscle‐invasive bladder cancer

BJU International
2025-01 | Journal article
DOI: 10.1111/bju.16493
Contributors: Kang Liu; Rossella Nicoletti; Hongda Zhao; Xuan Chen; Peter Ka‐Fung Chiu; Chi‐Fai Ng; Renate Pichler; Laura S. Mertens; Takafumi Yanagisawa; Luca Afferi et al.
Source: check_circle
Crossref

Changes in the treatment landscape of metastatic hormone‐sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter study

International Journal of Urology
2024-11 | Journal article
DOI: 10.1111/iju.15546
Contributors: Fumihiko Urabe; Katsuki Muramoto; Takafumi Yanagisawa; Wataru Fukuokaya; Keiichiro Mori; Kojiro Tashiro; Kota Katsumi; Hidetsugu Takahashi; Kentaro Yoshihara; Keiichiro Miyajima et al.
Source: check_circle
Crossref

First-line therapy for metastatic renal cell carcinoma: A propensity score-matched comparison of efficacy and safety

Urologic Oncology: Seminars and Original Investigations
2024-11 | Journal article
DOI: 10.1016/j.urolonc.2024.06.013
Contributors: Takafumi Yanagisawa; Keiichiro Mori; Tatsushi Kawada; Satoshi Katayama; Taizo Uchimoto; Takuya Tsujino; Kazuki Nishimura; Takahiro Adachi; Shingo Toyoda; Takuhisa Nukaya et al.
Source: check_circle
Crossref

Surveillance of non‐muscle‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis

BJU International
2024-10 | Journal article
DOI: 10.1111/bju.16364
Contributors: Reza Sari Motlagh; Alireza Ghoreifi; Takafumi Yanagisawa; Tatsushi Kawada; Sascha Ahyai; Axel S. Merseburger; Mohammad Abufaraj; Michael Abern; Hooman Djaladat; Siamak Daneshmand et al.
Source: check_circle
Crossref

Publisher Correction: Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis

Prostate Cancer and Prostatic Diseases
2024-10-07 | Journal article
DOI: 10.1038/s41391-024-00902-3
Contributors: Akihiro Matsukawa; Takafumi Yanagisawa; Mehdi Kardoust Parizi; Ekaterina Laukhtina; Jakob Klemm; Tamás Fazekas; Keiichiro Mori; Shoji Kimura; Alberto Briganti; Guillaume Ploussard et al.
Source: check_circle
Crossref

Association between concomitant proton pump inhibitor use and survival of patients with metastatic prostate cancer receiving abiraterone acetate: a post-hoc analysis of pooled data from three randomized controlled trials

Prostate Cancer and Prostatic Diseases
2024-09 | Journal article
DOI: 10.1038/s41391-023-00695-x
Contributors: Wataru Fukuokaya; Keiichiro Mori; Takafumi Yanagisawa; Kohei Akazawa; Tatsuya Shimomura; Takahiro Kimura
Source: check_circle
Crossref

First‐line immunotherapy of metastatic renal cell carcinoma: an updated network meta‐analysis including triplet therapy

BJU International
2024-09 | Journal article
DOI: 10.1111/bju.16336
Contributors: Takafumi Yanagisawa; Tatsushi Kawada; Kensuke Bekku; Ekaterina Laukhtina; Pawel Rajwa; Markus von Deimling; Marcin Chlosta; Fahad Quhal; Benjamin Pradere; Pierre I. Karakiewicz et al.
Source: check_circle
Crossref

Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis

Prostate Cancer and Prostatic Diseases
2024-09-13 | Journal article
DOI: 10.1038/s41391-024-00890-4
Contributors: Akihiro Matsukawa; Takafumi Yanagisawa; Tamas Fazekas; Marcin Miszczyk; Ichiro Tsuboi; Mehdi Kardoust Parizi; Ekaterina Laukhtina; Jakob Klemm; Stefano Mancon; Keiichiro Mori et al.
Source: check_circle
Crossref

Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis

Prostate Cancer and Prostatic Diseases
2024-09-05 | Journal article
DOI: 10.1038/s41391-024-00886-0
Contributors: Akihiro Matsukawa; Takafumi Yanagisawa; Mehdi Kardoust Parizi; Ekaterina Laukhtina; Jakob Klemm; Tamás Fazekas; Keiichiro Mori; Shoji Kimura; Alberto Briganti; Guillaume Ploussard et al.
Source: check_circle
Crossref

Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en‐bloc transurethral resection

Histopathology
2024-07 | Journal article
DOI: 10.1111/his.15177
Contributors: Takafumi Yanagisawa; Shun Sato; Yasushi Hayashida; Yohei Okada; Akihiro Matsukawa; Kosuke Iwatani; Masayuki Shimoda; Hiroyuki Takahashi; Takahiro Kimura; Shahrokh F Shariat et al.
Source: check_circle
Crossref

Role of Lutetium Radioligand Therapy in Prostate Cancer

Cancers
2024-07-01 | Journal article
DOI: 10.3390/cancers16132433
Contributors: Ignacy Książek; Artur Ligęza; Franciszek Drzymała; Adam Borek; Marcin Miszczyk; Marcin Radosław Francuz; Akihiro Matsukawa; Takafumi Yanagisawa; Tamás Fazekas; Łukasz Zapała et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study

Clinical Genitourinary Cancer
2024-06 | Journal article
DOI: 10.1016/j.clgc.2024.102082
Contributors: Chisato Narita; Fumihiko Urabe; Wataru Fukuokaya; Kosuke Iwatani; Yu Imai; Keiji Yasue; Keiichiro Mori; Koichi Aikawa; Takafumi Yanagisawa; Shoji Kimura et al.
Source: check_circle
Crossref

Percutaneous cryoablation of renal cell carcinomas in patients with Von Hippel‐Lindau disease: Functional and oncological outcomes

International Journal of Urology
2024-04 | Journal article
DOI: 10.1111/iju.15381
Contributors: Akihiro Matsukawa; Takafumi Yanagisawa; Kanichiro Shimizu; Shahrokh F. Shariat; Takahiro Kimura; Jun Miki
Source: check_circle
Crossref

Prognostic factors for overall survival in clinical node‐positive patients with upper tract urothelial carcinoma

International Journal of Urology
2024-04 | Journal article
DOI: 10.1111/iju.15380
Contributors: Taishiro Sasahara; Takafumi Yanagisawa; Shingo Sugaya; Akira Hisakane; Keigo Sakanaka; Shuhei Hara; Takashi Otsuka; Shigeaki Takamizawa; Yuji Yata; Yusuke Takahashi et al.
Source: check_circle
Crossref

Urinary function in female patients after traditional, organ‐sparing and nerve‐sparing radical cystectomy for bladder cancer: a systematic review and pooled analysis

BJU International
2024-03 | Journal article
DOI: 10.1111/bju.16152
Contributors: Ekaterina Laukhtina; Markus von Deimling; Benjamin Pradere; Takafumi Yanagisawa; Pawel Rajwa; Tatsushi Kawada; Fahad Quhal; Maximilian Pallauf; Alberto Bianchi; Muhammad Majdoub et al.
Source: check_circle
Crossref

Impact of timing of urinary drainage on clinical outcomes in patients with obstructive pyelonephritis associated with upper urinary tract stones: a propensity score-matched analysis

World Journal of Urology
2024-03-13 | Journal article
DOI: 10.1007/s00345-024-04871-z
Contributors: Sotaro Kayano; Takafumi Yanagisawa; Yuji Yata; Keiichiro Miyajima; Shuhei Hara; Kosuke Iwatani; Taishiro Sasahara; Yu Imai; Masaya Murakami; Kenichi Hata et al.
Source: check_circle
Crossref

Adjuvant immunotherapy in patients with renal cell carcinoma and urothelial carcinoma: A systematic review and network meta‐analysis

International Journal of Urology
2024-01 | Journal article
DOI: 10.1111/iju.15319
Contributors: Keiichiro Mori; Takafumi Yanagisawa; Wataru Fukuokaya; Kosuke Iwatani; Akihiro Matsukawa; Satoshi Katayama; Benjamin Pradere; Ekaterina Laukhtina; Pawel Rajwa; Marco Moschini et al.
Source: check_circle
Crossref

Repeat Transurethral Resection for Non–muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era

European Urology Focus
2024-01 | Journal article
DOI: 10.1016/j.euf.2023.07.002
Contributors: Takafumi Yanagisawa; Tatsushi Kawada; Markus von Deimling; Kensuke Bekku; Ekaterina Laukhtina; Pawel Rajwa; Marcin Chlosta; Benjamin Pradere; David D'Andrea; Marco Moschini et al.
Source: check_circle
Crossref

Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer

Urologic Oncology: Seminars and Original Investigations
2023-12 | Journal article
DOI: 10.1016/j.urolonc.2023.08.004
Contributors: Takafumi Yanagisawa; Shun Sato; Yasushi Hayashida; Yohei Okada; Wataru Fukuokaya; Kosuke Iwatani; Akihiro Matsukawa; Masayuki Shimoda; Hiroyuki Takahashi; Takahiro Kimura et al.
Source: check_circle
Crossref

Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate‐specific antigen concentrations

The Prostate
2023-11 | Journal article
DOI: 10.1002/pros.24609
Contributors: Aleksander Ślusarczyk; Michael Baboudjian; Piotr Zapała; Takafumi Yanagisawa; Marcin Miszczyk; Marcin Chlosta; Paul Krumpoeck; Marco Moschini; Giorgio Gandaglia; Guillaume Ploussard et al.
Source: check_circle
Crossref

Association Between Age and Efficacy of First-Line Immunotherapy-Based Combination Therapies for Mrcc: A Meta-Analysis

Immunotherapy
2023-10 | Journal article
DOI: 10.2217/imt-2023-0039
Contributors: Takafumi Yanagisawa; Fahad Quhal; Tatsushi Kawada; Kensuke Bekku; Ekaterina Laukhtina; Pawel Rajwa; Markus von Deimling; Marcin Chlosta; Benjamin Pradere; Pierre I Karakiewicz et al.
Source: check_circle
Crossref

Impact of performance status on efficacy of systemic therapy for prostate cancer: a meta‐analysis

BJU International
2023-10 | Journal article
DOI: 10.1111/bju.16106
Contributors: Takafumi Yanagisawa; Tatsushi Kawada; Keiichiro Mori; Sung Ryul Shim; Hadi Mostafaei; Reza Sari Motlagh; Fahad Quhal; Ekaterina Laukhtina; Markus von Deimling; Alberto Bianchi et al.
Source: check_circle
Crossref

Performance of Neck Imaging Reporting and Data System (NI-RADS) for Diagnosis of Recurrence of Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-analysis

American Journal of Neuroradiology
2023-10 | Journal article
DOI: 10.3174/ajnr.A7992
Contributors: Akira Baba; Ryo Kurokawa; Mariko Kurokawa; Takafumi Yanagisawa; Ashok Srinivasan
Source: check_circle
Crossref

Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis

Journal of Urology
2023-09 | Journal article
DOI: 10.1097/JU.0000000000003594
Contributors: Takafumi Yanagisawa; Pawel Rajwa; Tatsushi Kawada; Keiichiro Mori; Wataru Fukuokaya; Patrik Petrov; Fahad Quhal; Ekaterina Laukhtina; Markus von Deimling; Alberto Bianchi et al.
Source: check_circle
Crossref

Low-Dose or -Number of BCG in Non-Muscle Invasive Bladder Cancer: Updated Systematic Review and Meta-Analysis

Immunotherapy
2023-08 | Journal article
DOI: 10.2217/imt-2022-0309
Contributors: Tatsushi Kawada; Takafumi Yanagisawa; Kensuke Bekku; Ekaterina Laukhtina; Markus von Deimling; Mohammed Majdoub; Marcin Chlosta; Benjamin Pradere; Marko Babjuk; Paolo Gontero et al.
Source: check_circle
Crossref

Role of pelvic drain and timing of urethral catheter removal following RARP: a systematic review and meta‐analysis

BJU International
2023-08 | Journal article
DOI: 10.1111/bju.16022
Contributors: Takafumi Yanagisawa; Tatsushi Kawada; Hadi Mostafaei; Reza Sari Motlagh; Fahad Quhal; Ekaterina Laukhtina; Pawel Rajwa; Markus von Deimling; Alberto Bianchi; Maximilian Pallauf et al.
Source: check_circle
Crossref

Reply to Huseyin Besiroglu's Letter to the Editor regarding the article ‘Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?’

BJU International
2023-07 | Journal article
DOI: 10.1111/bju.16035
Contributors: Takafumi Yanagisawa; Jun Miki; Shun Sato; Hiroyuki Takahashi; Shahrokh F. Shariat; Takahiro Kimura
Source: check_circle
Crossref

ASO Author Reflections: Is T1HG Bladder Cancer a Good Candidate for En Bloc Resection?

Annals of Surgical Oncology
2023-06 | Journal article
DOI: 10.1245/s10434-023-13291-z
Contributors: Takafumi Yanagisawa; Jun Miki; Akihiro Matsukawa; Kosuke Iwatani; Shun Sato; Yasushi Hayashida; Yohei Okada; Masayuki Shimoda; Hiroyuki Takahashi; Shahrokh F. Shariat et al.
Source: check_circle
Crossref

ASO Visual Abstract: En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis

Annals of Surgical Oncology
2023-06 | Journal article
DOI: 10.1245/s10434-023-13395-6
Contributors: Takafumi Yanagisawa; Akihiro Matsukawa; Kosuke Iwatani; Shun Sato; Yasushi Hayashida; Yohei Okada; Takashi Yorozu; Wataru Fukuokaya; Keigo Sakanaka; Fumihiko Urabe et al.
Source: check_circle
Crossref

En Bloc Resection Versus Conventional TURBT for T1HG Bladder Cancer: A Propensity Score-Matched Analysis

Annals of Surgical Oncology
2023-06 | Journal article
DOI: 10.1245/s10434-023-13227-7
Contributors: Takafumi Yanagisawa; Akihiro Matsukawa; Kosuke Iwatani; Shun Sato; Yasushi Hayashida; Yohei Okada; Takashi Yorozu; Wataru Fukuokaya; Keigo Sakanaka; Fumihiko Urabe et al.
Source: check_circle
Crossref

Oncological impact of cystoscopic findings in non‐muscle‐invasive bladder cancer: a meta‐analysis

BJU International
2023-06 | Journal article
DOI: 10.1111/bju.15944
Contributors: Takafumi Yanagisawa; Fahad Quhal; Tatsushi Kawada; Hadi Mostafaei; Reza Sari Motlagh; Ekaterina Laukhtina; Pawel Rajwa; Markus von Deimling; Alberto Bianchi; Maximilian Pallauf et al.
Source: check_circle
Crossref

Docetaxel versus abiraterone for metastatic hormone‐sensitive prostate cancer with focus on efficacy of sequential therapy

The Prostate
2023-05 | Journal article
DOI: 10.1002/pros.24488
Contributors: Takafumi Yanagisawa; Kenichi Hata; Shintaro Narita; Shingo Hatakeyama; Keiichiro Mori; Yuji Yata; Takayuki Sano; Takashi Otsuka; Shuhei Hara; Keiichiro Miyajima et al.
Source: check_circle
Crossref

Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta‐analysis

BJU International
2023-05 | Journal article
DOI: 10.1111/bju.15913
Contributors: Takafumi Yanagisawa; Keiichiro Mori; Fahad Quhal; Tatsushi Kawada; Hadi Mostafaei; Ekaterina Laukhtina; Pawel Rajwa; Reza Sari Motlagh; Abdulmajeed Aydh; Frederik König et al.
Source: check_circle
Crossref

Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis

World Journal of Urology
2023-05-20 | Journal article
DOI: 10.1007/s00345-023-04412-0
Contributors: Takafumi Yanagisawa; Tatsushi Kawada; Fahad Quhal; Kensuke Bekku; Ekaterina Laukhtina; Pawel Rajwa; Markus von Deimling; Muhammad Majdoub; Marcin Chlosta; Benjamin Pradere et al.
Source: check_circle
Crossref

Sequencing impact and prognostic factors in metastatic castration-resistant prostate cancer patients treated with cabazitaxel: A systematic review and meta-analysis

Urologic Oncology: Seminars and Original Investigations
2023-04 | Journal article
DOI: 10.1016/j.urolonc.2022.06.018
Contributors: Takafumi Yanagisawa; Tatsushi Kawada; Pawel Rajwa; Hadi Mostafaei; Reza Sari Motlagh; Fahad Quhal; Ekaterina Laukhtina; Frederik König; Maximilian Pallauf; Benjamin Pradere et al.
Source: check_circle
Crossref

Association between concomitant proton pump inhibitor use and survival of patients with metastatic prostate cancer receiving abiraterone acetate: a post-hoc analysis of pooled data from three randomized controlled trials

2023-04-25 | Preprint
DOI: 10.21203/rs.3.rs-2834713/v1
Contributors: Wataru Fukuokaya; Keiichiro Mori; Takafumi Yanagisawa; Kohei Akazawa; Tatsuya Shimomura; Takahiro Kimura
Source: check_circle
Crossref

Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review

Journal of Personalized Medicine
2023-04-07 | Journal article
DOI: 10.3390/jpm13040641
Contributors: Takafumi Yanagisawa; Pawel Rajwa; Fahad Quhal; Tatsushi Kawada; Kensuke Bekku; Ekaterina Laukhtina; Markus von Deimling; Marcin Chlosta; Pierre I. Karakiewicz; Takahiro Kimura et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

C-reactive Protein is a Strong Prognostic Factor for Overall Survival in Clinically Node-positive Patients with Upper Tract Urothelial Carcinoma

2023-04-06 | Preprint
DOI: 10.21203/rs.3.rs-2742420/v1
Contributors: Taishiro Sasahara; Takafumi Yanagisawa; Shingo Sugaya; Akira Hisakane; Keigo Sakanaka; Shuhei Hara; Takashi Otsuka; Shigeaki Takamizawa; Yuji Yata; Yusuke Takahashi et al.
Source: check_circle
Crossref

Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis

Prostate Cancer and Prostatic Diseases
2023-03 | Journal article
DOI: 10.1038/s41391-022-00607-5
Contributors: Pawel Rajwa; Takafumi Yanagisawa; Isabel Heidegger; Fabio Zattoni; Giancarlo Marra; Timo F. W. Soeterik; Roderick C. N. van den Bergh; Massimo Valerio; Francesco Ceci; Claudia V. Kesch et al.
Source: check_circle
Crossref

Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?

BJU International
2023-02 | Journal article
DOI: 10.1111/bju.15760
Contributors: Takafumi Yanagisawa; Shun Sato; Yasushi Hayashida; Yohei Okada; Kosuke Iwatani; Akihiro Matsukawa; Takahiro Kimura; Hiroyuki Takahashi; Shin Egawa; Shahrokh F. Shariat et al.
Source: check_circle
Crossref

Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity

Cancers
2023-02-13 | Journal article
DOI: 10.3390/cancers15041180
Contributors: Marcin Miszczyk; Małgorzata Kraszkiewicz; Matthias Moll; Konrad Kaminiów; Szymon Sobel; Łukasz Dolla; Piotr Wojcieszek; Paweł Rajwa; Takafumi Yanagisawa; Zuzanna Nowicka et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer

Current Oncology
2023-02-10 | Journal article
DOI: 10.3390/curroncol30020170
Contributors: Takafumi Yanagisawa; Pawel Rajwa; Tatsushi Kawada; Kensuke Bekku; Ekaterina Laukhtina; Markus von Deimling; Muhammad Majdoub; Marcin Chlosta; Pierre I. Karakiewicz; Axel Heidenreich et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Does castration status affect docetaxel‐related adverse events? :Identification of risk factors for docetaxel‐related adverse events in metastatic prostate cancer

The Prostate
2022-10 | Journal article
DOI: 10.1002/pros.24406
Contributors: Takafumi Yanagisawa; Takahiro Kimura; Kenichi Hata; Shintaro Narita; Shingo Hatakeyama; Yuki Enei; Mahito Atsuta; Keiichiro Mori; Koki Obayashi; Kentaro Yoshihara et al.
Source: check_circle
Crossref

Effect of upfront intensive therapy on oncological outcomes in older patients with high tumor burden metastatic castration‐sensitive prostate cancer: A multicenter retrospective study

The Prostate
2022-09 | Journal article
DOI: 10.1002/pros.24404
Contributors: Yuki Miura; Shingo Hatakeyama; Shintaro Narita; Takahiro Kimura; Kenichi Hata; Takafumi Yanagisawa; Toshikazu Tanaka; Noritaka Ishi; Sadafumi Kawamura; Senji Hoshi et al.
Source: check_circle
Crossref

Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis

Urologic Oncology: Seminars and Original Investigations
2022-07 | Journal article
DOI: 10.1016/j.urolonc.2022.04.002
Contributors: Takafumi Yanagisawa; Keiichiro Mori; Tatsushi Kawada; Reza Sari Motlagh; Hadi Mostafaei; Fahad Quhal; Ekaterina Laukhtina; Pawel Rajwa; Abdulmajeed Aydh; Frederik König et al.
Source: check_circle
Crossref
Items per page:
Page 1 of 2

Peer review (32 reviews for 8 publications/grants)

Review activity for Clinical and experimental nephrology. (3)
Review activity for Clinical genitourinary cancer. (1)
Review activity for European urology oncology. (21)
Review activity for European urology. (1)
Review activity for Heliyon. (1)
Review activity for Targeted oncology. (1)
Review activity for World journal of surgical oncology (1)
Review activity for World journal of urology. (3)
How many people are using ORCID?